The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationDrugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Self-citationThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 739
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Self-citation
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 998
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Self-citationThe past, present, and future of antibiotics
Cook, M. A., & Wright, G. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7793 · Cited by 652
Self-citationAntimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Next-generation approaches to understand and combat the antibiotic resistome
Crofts, T. S., Gasparrini, A. J., & Dantas, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.28 · Cited by 535
A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens
Song, M., Liu, Y., Huang, X., Ding, S., Wang, Y., Shen, J., & Zhu, K. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0723-z · Cited by 484
Li, T., Wang, P., Guo, W., Huang, X., Tian, X., Wu, G., Xu, B., Li, F., Yan, C., Liang, X.-J., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01346 · Cited by 462
Antibiotic resistance breakers: current approaches and future directions
Laws, M., Shaaban, A., & Rahman, K. M. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz014 · Cited by 356
Opportunities for natural products in 21st century antibiotic discovery
Wright, G. D. (2017) · Natural Product Reports · doi:10.1039/c7np00019g · Cited by 343
Self-citationMultidrug-resistant Gram-negative bacterial infections
Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02081-6 · Cited by 315
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L. (2020) · Advanced Science · doi:10.1002/advs.201901872 · Cited by 314
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Antibiotic Adjuvants: Make Antibiotics Great Again!
Douafer, H., Andrieu, V., Phanstiel, O., & Brunel, J. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01781 · Cited by 272
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
Yang, J. H., Bhargava, P., McCloskey, D., Mao, N., Palsson, B. O., & Collins, J. J. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.020 · Cited by 267
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong, T., Salabarria, A.-C., & Roach, D. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.014 · Cited by 266
Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance
Manniello, M. D., Moretta, A., Salvia, R., Scieuzo, C., Lucchetti, D., Vogel, H., Sgambato, A., & Falabella, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03784-z · Cited by 259
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 256
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Bacterial proteases, untapped antimicrobial drug targets
Culp, E., & Wright, G. D. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.138 · Cited by 244
Self-citationAntibiotic resistance: turning evolutionary principles into clinical reality
Andersson, D. I., Balaban, N. Q., Baquero, F., Courvalin, P., Glaser, P., Gophna, U., Kishony, R., Molin, S., & Tønjum, T. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa001 · Cited by 238
Fatty acids as antibiofilm and antivirulence agents.
Kumar, P., Lee, J.-H., Beyenal, H., & Lee, J. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.014 · Cited by 216
Saputo, S., Faustoferri, R. C., & Quivey, R. G. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01674-17 · Cited by 29
CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
Huang, L., Wang, J., Fang, B., Meric-Bernstam, F., Roth, J. A., & Ha, M. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-16933-6 · Cited by 21
Gillard, K., Miller, H. B., & Blackledge, M. S. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13361 · Cited by 20
Metadata
- Authors
- Wright, G. D.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2016-11
- Volume
- 24
- Issue
- 11
- Pages
- 862-871
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2489596030
- Cited by
- 604
- References
- 54
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.